These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10989823)

  • 1. Current issues in the treatment of resistant bloodstream infections.
    Wade JC
    Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):35-9. PubMed ID: 10989823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatments for infection in neutropenic patients with hematologic malignancy.
    Greene JN; Linch DC; Miller CB
    Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):31-4. PubMed ID: 10989822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of infections and antimicrobial susceptibilities.
    Maschmeyer G; Noskin GA; Ribaud P; Sepkowitz KA
    Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):9-16. PubMed ID: 10989819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
    Barber GR; Lauretta J; Saez R
    Pharmacotherapy; 2007 Jun; 27(6):927-32. PubMed ID: 17542774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
    Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
    J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin resistant enterococcal sepsis in an acute myeloid leukemic patient.
    Sattar A; Abbasi SA; Mirza IA; Malik N; Ahmed P; Faqir F
    J Coll Physicians Surg Pak; 2010 Dec; 20(12):830-1. PubMed ID: 21205553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Daptomycin in Gram-positive bacterial infections in oncohematological patients and transplant recipients].
    Carratalà J; Len O; de la Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():43-9. PubMed ID: 22541975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting antibiotics for nosocomial bacterial infections in patients requiring neonatal intensive care.
    Payne NR; Schilling CG; Steinberg S
    Neonatal Netw; 1994 Apr; 13(3):41-51. PubMed ID: 8152410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
    Krueger WA; Unertl KE
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.
    Nelson RR
    J Hosp Infect; 1999 Aug; 42(4):275-82. PubMed ID: 10467540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the choice and administration of agents for empiric antimicrobial therapy.
    Baughman RP
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-71-82. PubMed ID: 23577498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing optimal antimicrobial therapies.
    Lynch TJ
    Med Clin North Am; 2012 Nov; 96(6):1079-94. PubMed ID: 23102478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches for empiric therapy in Gram-positive sepsis.
    Bassetti M; Ginocchio F; Giacobbe DR
    Minerva Anestesiol; 2011 Aug; 77(8):821-7. PubMed ID: 21730930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.